T. Rowe Price Investment Management, Inc. Procept Bio Robotics Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,415,403 shares of PRCT stock, worth $77 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,415,403
Previous 985,942
43.56%
Holding current value
$77 Million
Previous $79.4 Million
3.87%
% of portfolio
0.05%
Previous 0.05%
Shares
11 transactions
Others Institutions Holding PRCT
# of Institutions
292Shares Held
39.9MCall Options Held
196KPut Options Held
142K-
Vanguard Group Inc Valley Forge, PA5.13MShares$279 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$190 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$95.4 Million0.05% of portfolio
-
State Street Corp Boston, MA1.19MShares$64.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.18MShares$64.4 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.43B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...